Peak Pharma Prepares for Human Marketplace as Veterinary Segment Propels Early Commercial Success

There’s a growing and increasingly vocal body of researchers showing that cannabidiol (“CBD”) – the non-psychoactive component of the cannabis plant – could provide substantial health benefits. While GW Pharmaceuticals plc (NASDAQ: GWPH) has pioneered clinical trials in the space, this research suggests that the company is just scratching the surface of what may be…

The post Peak Pharma Prepares for Human Marketplace as Veterinary Segment Propels Early Commercial Success appeared first on Marijuana Index.